Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817517 · ClinicalTrials.gov registry record · NA
Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01817517: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT01817517 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01817517, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This research is being performed to try to understand if the use of deep brain stimulation or DBS can treat the symptoms of Tourette syndrome that do not respond well to current medications. In order to do this the investigators will place small stimulation leads on both sides of the brain in a region (a portion of the thalamus) that may alter the abnormal activity in the brain contributing to the symptoms of Tourette syndrome. This requires two surgical procedures, and several preoperative and postoperative visits for tuning the stimulation parameters and recording stimulation effects. The FDA has not approved DBS for use in people with Tourette syndrome, and Medtronic (the manufacturer of the device) has not conducted testing for the system in Tourette syndrome. Therefore its use in this study is experimental.
Interventions
- DEVICE Medtronic Activa Deep Brain Stimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-03 |
| Est. Completion | 2023-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01817517
The ClinicalTrials.gov registry entry for NCT01817517 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic Activa Deep Brain Stimulation System is the first listed.
NCT01817517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01817517 about?
NCT01817517 is a clinical study titled "Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome". This research is being performed to try to understand if the use of deep brain stimulation or DBS can treat the symptoms of Tourette syndrome that do not respond well to current medications. In order to do this the investigators will place small stimulation leads on both sides of the brain in a regi...
What is the current status of trial NCT01817517?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2014-03. Estimated completion is 2023-02-02.
What interventions are being tested in trial NCT01817517?
The interventions under investigation include: Medtronic Activa Deep Brain Stimulation System (DEVICE).
Who is sponsoring clinical trial NCT01817517?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.